The Nifty 50 rose 183 points to reclaim the 24,000 level on Thursday as midcap indices outperformed. While broader market sentiment turned positive, Dr. Reddy’s Laboratories shares dropped over 5% on high trading volumes. Investors are keeping a close watch on geopolitical tensions and upcoming IT sector earnings.
Indian equity markets staged a sharp recovery on Thursday, July 9, 2026, with the Nifty 50 closing at 24,065.15, up by 183.10 points. The Sensex followed a similar trajectory, gaining 551.19 points to settle at 77,054.79. This rebound effectively reversed the losses from the previous session, as broader indices signaled a return of investor appetite for riskier assets.
Broader Market Outperformance
The recovery was led by midcap and small-cap stocks, which outperformed the benchmark indices. The Nifty Midcap 100 gained 1.48%, while the Nifty Small Cap 100 saw a stronger rise of 1.70%. The market breadth remained positive, with 94 stocks reaching new 52-week highs on the BSE compared to 60 stocks touching new lows. This suggests that despite the volatility linked to the weekly Sensex expiry, buying interest remained sustained across various segments of the market.
Dr. Reddy’s Laboratories Faces Selling Pressure
While the pharmaceutical sector generally saw positive momentum, Dr. Reddy’s Laboratories stood out as a significant exception. The stock fell 5.31% during the session, witnessing exceptionally heavy trading volumes. This decline occurred even as other major pharmaceutical companies, such as Sun Pharmaceutical, recorded gains of 2.50%. For investors, this divergence is a notable monitorable. Heavy volumes during a price drop often indicate a high level of institutional or large-scale selling, though the company has not issued a specific exchange filing regarding this movement as of midday.
Factors Impacting Market Sentiment
Several macroeconomic and geopolitical factors continue to influence market movements. Geopolitical tensions in the Middle East, particularly those impacting the Strait of Hormuz, are keeping energy markets sensitive. With crude oil prices remaining elevated, sectors reliant on fuel may face cost pressures. Additionally, the Indian rupee continues to trade near the ₹95.5 mark against the US dollar, a factor that often influences foreign investor behavior.
Looking ahead, the market is turning its focus toward the upcoming quarterly earnings season. IT stocks, such as Infosys, are already seeing selling pressure, with the stock falling 1.34% today. Investors will likely look for guidance on revenue growth and profit margins in the coming weeks to determine if the current broad-market recovery can be sustained. The primary monitorables for the near term include Foreign Institutional Investor (FII) net flow data and the impact of the rupee’s movement on import-heavy industries.